Jsf Financial, LLC Abb Vie Inc. Transaction History

Jsf Financial, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $496,687 - $574,988	3,718 New	3,718 $554,000
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $469,834 - $597,313	-3,414 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $450,579 - $559,042	3,414 New	3,414 $553,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Jsf Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jsf Financial, LLC with notifications on news.